Sanofi showcases eczema data ahead of EU decision
Dupixent predicted to be blockbuster for Sanofi
X
Sanofi showcases eczema data ahead of EU decision
https://pharmaphorum.com/news/dupixent-data-sanofi-ahead-eu-decision/
eczema
Roche sells rights to troubled asthma and eczema drug
Dermira will focus on development in eczema.
Sanofi/Regeneron eczema data paves way for year’s biggest launch
Companies look to take on Pfizer after series of setbacks.
Sanofi’s dermatitis drug dupilumab fast-tracked by FDA
Drug could earn $2.8 billion if approved in AD and asthma
Giving antibiotics to children increases allergy risk
Antibiotics linked with asthma and eczema link.
